Brief: Fennec Pharmaceuticals reports Q2 results

Fennec Pharmaceuticals

12/08/2022 12:14

Aug 12 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * FENNEC PHARMACEUTICALS INC - PEDMARK FDA PRESCRIPTION DRUG
USER
FEE ACT (PDUFA) TARGET ACTION DATESET FOR SEPTEMBER 23, 2022
    * FENNEC PHARMACEUTICALS INC- QTRLY DILUTED NET LOSS $0.19
PER
SHARE
    * FENNEC PHARMACEUTICALS INC- CASH AND CASH EQUIVALENTS WERE
$14.9
MILLION AS OF JUNE 30, 2022

Source text for Eikon:  ID:nGNX5FKHB 
Further company coverage:  FENC.O